Piotr Michal Terlecki

Prof. Piotr Michal Terlecki

Medical University of Lublin, Lublin, Lubelskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2017 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
AHAnna Horecka
Anna Horecka
JBJadwiga Biernacka
Jadwiga Biernacka
AHAnna Horecka
Anna Horecka
WDWojciech Dabrowski
Wojciech Dabrowski
Piotr Michal TerleckiPiotr Michal Terlecki
Piotr Michal Terlecki
Jacek KurzepaJacek Kurzepa
Jacek Kurzepa
Objective: Our objective was to evaluate the state of oxidative stress in the great saphenous varicose vein wall and blood of varicose vein patients taken from the antecubital vein.Methods: The superoxide dismutase, reduced glutathione (GSH) and total antioxidant status were measured with commercially available colorimetric kits in erythrocytes, plasma and varicose vein wall of 65 patients (second degree of clinical state classification, etiology, anatomy and pathophysiology) aged 22–70 (49 women, 16 men) in comparison to normal great saphenous vein walls collected from 10 patients who underwent coronary artery bypass graft and blood collected from 20 healthy individuals.Results: A statistically significant decrease (p < 0.001) in superoxide dismutase activity in erythrocytes and the increase (p < 0.05) in superoxide dismutase activity in varicose vein has been observed. There have been no significant changes in the concentration of GSH in plasma and in varicose vein. The decreased concentration of total antioxidant status in plasma (p < 0.001) and in varicose vein wall (p < 0.05) in comparison to the control has been noticed.Conclusion: The varicose vein patients are affected by oxidative stress. Our results indicate impaired antioxidant defense mechanism in the blood of varicose vein patients. In contrast to the blood, an increased process of antioxidant defense in the varicose vein wall was noticed.

15 February 2019 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
Piotr Michal TerleckiPiotr Michal Terlecki
Piotr Michal Terlecki
TZTomasz Zubilewicz
Tomasz Zubilewicz
AWAndrzej Wojtak
Andrzej Wojtak
EPEliza Pleban
Eliza Pleban
Stanislaw PrzywaraStanislaw Przywara
Stanislaw Przywara
PSPiotr Szopiński
Piotr Szopiński

6 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Piotr Michal TerleckiPiotr Michal Terlecki
Piotr Michal Terlecki
KTKarol Terlecki
Karol Terlecki
Stanislaw PrzywaraStanislaw Przywara
Stanislaw Przywara
MIMarek Iłżecki
Marek Iłżecki
MTMichal Toborek
Michal Toborek
TZTomasz Zubilewicz
Tomasz Zubilewicz
Background: Klippel–Trenaunay syndrome (KTS) is characterized by a triad of symptoms; varicose veins and venous malformations (VMs), capillary malformations (port-wine stain), and soft tissue and bone hypertrophy. Herein, we retrospectively studied six patients with KTS who underwent treatment with the Flebogrif system and evaluated their outcomes. Methods: Six KTS patients aged 16–22 years who had undergone 18 non-thermal ablations using the Flebogrif system were enrolled. All patients underwent multistage foam sclerotherapy with 3% polidocanol at 3–4-week intervals. Results: Venous clinical severity score (VCSS) analysis showed improvement in the patients’ clinical condition. All patients reported a significant improvement in aesthetic outcomes. One patient presented with recanalization of ablated marginal veins during the 24-month follow-up period. Patients could return to full activity within 7–10 days after the procedure. None of the patients experienced serious systemic complications. Conclusion: The use of the Flebogrif system in treating various forms of chronic venous insufficiency, including in patients with KTS, provides a high success rate with a high closure rate.

Arkadiusz Robert KrzyżanowskiArkadiusz Robert Krzyżanowski
Arkadiusz Robert Krzyżanowski
TGTomasz Gęca
Tomasz Gęca
BSBożena Sokołowska
Bożena Sokołowska
MKMaciej Kwiatek
Maciej Kwiatek
AMAndrzej Miturski
Andrzej Miturski
AKAnna Kwaśniewska
Anna Kwaśniewska
Introduction: Factor VII (FVII) deficiency is a rare hemorrhagic diathesis. In females, heavy menstrual and postpartum bleeding can appear as a consequence of its deficiency. Supplementation of the recombinant FVIIa is widely accepted. The supplementation effect in FVII-deficient subjects is difficult to predict, and severe hemorrhage has been described even when FVII levels after supplementation were within normal ranges. The aim of this report is to present the application of thromboelastometry to control the coagulation status in a patient with severe FVII deficiency during pregnancy and delivery, supplemented by rFVIIa per protocol complicated with life-threatening venous thromboembolism. Methods: Rotational thromboelastometry (ROTEM) was performed in 16 pregnant women: in one 28 year old primigravida at 35 weeks of pregnancy with congenital FVII deficiency after rFVIIa administration and 15 healthy women at 38 gestational weeks. The results were compared. Results: The thromboelastometry results showed significant shortening of the clotting time in the extrinsic and the intrinsic pathway in the hypoproconvertinemia patient after rFVIIa administration in relation to healthy pregnant women. A significant reduction in maximum lysis of the clot after FVII supplementation was observed. Conclusions: The thromboelastometry results showed a significant hypercoagulable state with hypoproconvertinemia. Thrombotic complications after delivery might be prevented by the reduction in rFVIIa guided by thromboelastometry. Thromboelastometry performed on a pregnant woman with factor VII deficiency during the supplementation of rFVIIa in peripartum time might be helpful in order to determine an individual, effective dosage regimen of rFVIIa to ensure full correction of clotting disorders without the tendency to develop thrombosis, but further studies are needed.

1 April 2022 in Materials
Verified
Journal Article
Open access
PDF file
Piotr Michal TerleckiPiotr Michal Terlecki
Piotr Michal Terlecki
MBMarek Boryga
Marek Boryga
PKPaweł Kołodziej
Paweł Kołodziej
KGKrzysztof Gołacki
Krzysztof Gołacki
ZSZbigniew Stropek
Zbigniew Stropek
TZTomasz Zubilewicz
Tomasz Zubilewicz
Non-thermal endovenous ablations, due to the lowest probability of complications, are the new method of treating chronic venous insufficiency—one of the most common diseases globally. The Flebogrif system (Balton Sp. z o.o., Warsaw, Poland) is a new mechano-chemical ablation system causing the mechanical damage of endothelium that allows for better sclerosant penetration into its wall. The purpose of the article is to provide mechanical characteristics in the form of force–displacement dependence for a single cutting element, and a bundle of cutting elements of Flebogrif as a whole for different levels of protrusion of the bundle of cutting elements. A TA.HD plus (Stable Micro Systems, Godalming, UK) analyzer equipped with special handles, was used for characteristics testing. The head movement speed used was 5 mm·s−1. The Flebogrif system was tested for three cutting element protrusion levels: L = Lmax, L = 0.9·Lmax, and L = 0.8·Lmax. Before testing, geometric measurement of the spacing of the cutting elements for three proposed protrusions was performed. It was established that decreasing the working length of the cutting elements will increase their rigidity, and, as a result, increase the force exerted on the internal surface of the vein wall. The obtained characteristics will allow for specifying contact force variability ranges and the corresponding diameter ranges of operated veins.

Piotr Michal TerleckiPiotr Michal Terlecki
Piotr Michal Terlecki
Stanislaw PrzywaraStanislaw Przywara
Stanislaw Przywara
KTKarol Terlecki
Karol Terlecki
DJDariusz Janczak
Dariusz Janczak
MAMaciej Antkiewicz
Maciej Antkiewicz
TZTomasz Zubilewicz
Tomasz Zubilewicz
Introduction: Endarterectomy and angioplasty of the internal carotid artery are surgical measures for the prevention of ischemic stroke. Perioperative complications are caused by concomitant embolism and reperfusion syndrome leading to damage of the blood–brain barrier. Methods: The study included 88 patients divided into two groups, depending on the surgical technique used: internal carotid artery endarterectomy (CEA), 66 patients, and percutaneous carotid angioplasty and stenting (CAS), 22 patients. Blood was drawn 24 h before surgery, as well as 8, 24, and 48 h post-surgery. The assessment of damage to the blood–brain barrier was based on the evaluation of the concentration of claudin-1 and occludin, aquaporin-4, the measurements of the activity of metalloproteinase-2 (MMP-2) and -9 (MMP-9), and the assessment of central nervous system damage, measured by changes in the blood S100β protein concentration. Results: A significant increase in the concentration of the blood–brain barrier damage markers and increased MMP-2 and MMP-9 activity were found in patient blood. The degree of damage to the blood–brain barrier was higher in the CEA group. Conclusions: The authors’ own research has indicated that revascularization of the internal carotid artery may lead to damage to the central nervous system secondary to damage to the blood–brain barrier.